CTX-3397

N/A

Report date: 2022/08/24 20:00:31

NME

Base Information

Drug NameCTX-3397

Drug Alias NameN/A

ClassificationOther

Mechanisms of ActionLeukotriene A-4 hydrolase inhibitors

TargetsLeukotriene A-4 hydrolase

Therapy Area/IndicationsMultiple Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCeltaxsys Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCeltaxsys Inc

Active IndicationsN/A

Inactive IndicationsMultiple Sclerosis

ATC CodeN/A